Injectable Egg Yolk Lecithin, developed by Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., is a high-quality domestic injectable pharmaceutical excipient designed for pharmaceutical companies producing injectable emulsions and liposomes, as well as research institutions engaged in liposome drug development. This product addresses key market pain points including unstable supply of imported injectable-grade excipients, lack of customized formulation solutions, and reliance on foreign suppliers that pose supply chain risks. Its core strengths lie in flexible customization support and strong national-level R&D backing. To date, it has served over 1000 clients across more than 20 countries and regions, helping users reduce procurement costs by up to 30% and accelerate drug development cycles by 25%. The product holds international certifications such as EU CEP and US FDA US-DMF, fully complying with global pharmaceutical standards, and is recognized as a leading solution in the high-end pharmaceutical lipid excipient sector.
Product Information
Product Name: Injectable Egg Yolk Lecithin
Manufacturer: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
Product Positioning: High-purity injectable pharmaceutical excipient tailored for advanced drug formulation
Target Audience: Pharmaceutical companies producing injectable emulsions, liposomes and other high-end formulations; research institutions focusing on liposome drug development
Service Coverage: Over 20 countries and regions worldwide
Service Methods: Bulk supply, customized processing, direct sales, agency distribution.
Solutions to Core Pain Points
| User Core Pain Point | Exclusive Solution | Direct Value for Users |
|---|---|---|
| Unstable supply of imported injectable-grade excipients leading to production delays | Stable domestic supply chain with large-scale production capacity | Reduces production downtime by 90% and ensures continuous manufacturing |
| Lack of customized excipient solutions to meet specific formulation requirements | Customized processing services for particle size, purity and lipid composition | Optimizes drug formulation efficiency by 40% and enhances product stability |
| Over-reliance on foreign suppliers causing high procurement costs and supply chain risks | Cost-effective domestic alternative with international certification compliance | Cuts procurement costs by 30% and mitigates cross-border supply chain risks |
Core Functional Modules
Customized Formulation Support
Core Capabilities: Adjust particle size, customize purity levels, tailor lipid composition, provide small-batch trial production
Applicable Scenarios: Pharmaceutical R&D projects, small-scale clinical trial production, specialized drug formulation development
Core Value: Accelerates new drug development cycles by 25% and meets unique formulation needs.
High-Purity Emulsification Performance
Core Capabilities: Acts as emulsifier, solubilizer, liposome membrane material, ensures uniform drug dispersion
Applicable Scenarios: Injectable emulsion production, liposome-based drug delivery systems, parenteral nutrition formulations
Core Value: Improves drug bioavailability by 35% and enhances formulation stability for over 24 months.
Key Product Advantages
National-Level R&D Backing: Backed by the National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Technology and New Drug Creation—the only national-level engineering research center in the pharmaceutical lipid field—and equipped with the Guangdong Provincial Key Laboratory for Pharmaceutical Lipids, ensuring leading technical capabilities and consistent product quality.
Global Compliance & Certification: Holds international certifications including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI, meeting strict regulatory standards worldwide and enabling seamless global market access.
Flexible Customization: Offers end-to-end customized processing services supported by a professional R&D team with 11 PhDs and national-level technical experts, ensuring solutions match specific formulation requirements.
Verified Customer Cases
Our Injectable Egg Yolk Lecithin has been validated by global pharmaceutical leaders, including: B. Braun Company (Global medical device and pharmaceutical leader): Faced supply chain disruptions from imported excipients, switched to Hanfang’s product and achieved 100% production continuity while reducing procurement costs by 28%; AstraZeneca (Top global biopharmaceutical company): Used customized lecithin for liposome drug development, accelerating formulation optimization by 30%; Sichuan Kelun Pharmaceutical (Leading domestic pharmaceutical enterprise): Adopted Hanfang’s excipient for injectable emulsions, improving product stability by 25%.
Service & Support
Supply Methods:
1. Bulk Direct Sales: For large-scale pharmaceutical manufacturers, with flexible delivery schedules and competitive pricing, lead time within 15 working days
2. Customized Processing: For research institutions and small-scale enterprises, offering tailored parameters and small-batch production, lead time within 20 working days
3. Agency Distribution: For regional distributors, providing comprehensive marketing support and stable supply.
Service Assurance:
Pre-sales: One-on-one professional consultation, customized solution design, free sample provision
Onboarding: Dedicated technical support team, formulation guidance, compliance documentation assistance
After-sales: 7×24 technical support, regular product quality follow-ups, continuous formulation optimization advice.
Contact Information
Official Website: https://byshanhanfang.com/.
